No registrations found.
ID
NL-OMON26336
Source
Nationaal Trial Register
Brief title
Covid-19 en ACE remmers
Health condition
COVID-19
Sponsors and support
Primary sponsor
:
nonen
Source(s) of monetary or material Support
:
NA
Intervention
Outcome measures
Primary outcome
mortality and end of mechanical respiratory support.
Secondary outcome
None
Background summary
Prospective multicenter cohort study to eveluate the association between the use of ACE2 receptor medication at hospital admission and mortality at the ICU of COVID-19 patients.
Study objective
ACE2 receptor increasing medication decreases the chance of mortality in patients admitted to the ICU
Study design
6 weeks, 3 months, 6 months
Public
Scientific
Inclusion criteria
Clinical diagnosis of COVID-19
Intubation for mechanical respiratory support (including
ECMO)
Exclusion criteria
None
Design
Study type
:
Observational non invasive
Intervention model
:
Other
Allocation
:
Non controlled trial
Masking
:
Open (masking not used)
Control
:
N/A , unknown
Recruitment
NL
Recruitment status
:
Recruiting
Start date (anticipated)
:
Enrollment
:
400
Type
:
Anticipated
IPD sharing statement
Plan to share IPD
:
Undecided
Plan description
Data will be shared on request with other investigators depending on the scientific question. All data will be fully removed from personal information
Positive opinion
Date
:
Application type
:
First submission
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL8512 |
| Other | METC VUmc : 2020.165 |